Literature DB >> 24490830

Generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist successfully treated with granulocyte and monocyte adsorption apheresis.

K Sugiura1, K Haruna, Y Suga, M Akiyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24490830     DOI: 10.1111/jdv.12383

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  6 in total

Review 1.  Use of granulocyte and monocyte adsorption apheresis in dermatology (Review).

Authors:  Laura Gnesotto; Guido Mioso; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2022-06-24       Impact factor: 2.751

2.  A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis.

Authors:  Chiharu Tominaga; Masaaki Yamamoto; Yasutomo Imai; Kiyofumi Yamanishi
Journal:  Case Rep Dermatol       Date:  2015-02-21

3.  Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner.

Authors:  Pilar Alvarez; Liselotte E Jensen
Journal:  Mediators Inflamm       Date:  2016-12-12       Impact factor: 4.711

4.  IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.

Authors:  Charlie Bridgewood; Gareth W Fearnley; Anna Berekmeri; Philip Laws; Tom Macleod; Sreenivasan Ponnambalam; Martin Stacey; Anne Graham; Miriam Wittmann
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

5.  Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis.

Authors:  Asami Fujii; Yoko Mizutani; Yuki Hattori; Tomoko Takahashi; Hidenori Ohnishi; Shozo Yoshida; Mariko Seishima
Journal:  Case Rep Dermatol       Date:  2017-05-22

6.  Autoinflammatory Keratinization Diseases (AiKDs): Expansion of Disorders to Be Included.

Authors:  Masashi Akiyama
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.